SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) November 19, 2008
PHARMOS CORPORATION
(Exact name of Registrant as Specified in its Charter)
Nevada | 0-11550 | 36-3207413 |
(State or Other Jurisdiction | (Commission file Number) | (IRS Employer Identification No.) |
|
|
|
|
|
|
| 99 Wood Avenue South, Suite 311, Iselin, NJ | 08830 | |
| |||
| (Address of Principal Executive Offices) | (Zip Code) | |
|
|
| |
|
|
| |
Registrant’s telephone number, including area code (732) 452-9556 | |||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
o | Soliciting material pursuant to Rule 14a-2 under the Exchange Act (17 CFR 240.14a-2) |
|
|
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01 Other Events.
On November 19, 2008, Pharmos Corporation issued the press release attached hereto as Exhibt 99.1.
Item 9.01 Financial Statements and Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 20th day of November, 2008.
| PHARMOS CORPORATION | |
|
| |
|
| |
|
| |
| By: | /s/ S. Colin Neill |
| Name: S. Colin Neill | |
| Title: President and Chief Financial Officer | |
|
| |
|
| |